Severity of Imunisation Adverse (KIPI) Based on Allergic History and Vaccine Stages

Authors

Taufiqur Rahman , Abdan Syakura , Nur Rahma , Cantika Iva Nugrahani

DOI:

10.29303/jppipa.v11i4.7965

Published:

2025-04-25

Issue:

Vol. 11 No. 4 (2025): April

Keywords:

Allergic, Imunisation adverse, KIPI Reactions, Vaccination

Research Articles

Downloads

How to Cite

Rahman, T., Syakura, A., Rahma, N., & Nugrahani, C. I. (2025). Severity of Imunisation Adverse (KIPI) Based on Allergic History and Vaccine Stages. Jurnal Penelitian Pendidikan IPA, 11(4), 694–700. https://doi.org/10.29303/jppipa.v11i4.7965
Crossref
Scopus
Google Scholar
Europe PMC

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Abstract

Covid-19 prevention has also entered a new era with the availability of the Covid-19 vaccine, which has undergone clinical trials and has been mass-produced to enhance immunity. However, the administration of vaccinations has resulted in unexpected reactions known as Adverse Events Following Immunization (KIPI). This phenomenon suggests that low vaccination rates may be associated with perceived dangerous KIPI reactions, which can be attributed to doubts and misinformation about vaccines. This study used a correlation analytical research design with a retrospective method. The population of this study consisted of all individuals who had received vaccination and experienced KIPI reactions in the working area of Teja Health Center, totaling 30 people. The characteristics of the respondents, as seen from their allergic history and vaccine stages, showed a significant correlation (p = 0.027 < 0.05). The p-value for vaccine stages was 0.000, indicating a significant relationship with the severity of KIPI reactions in Covid-19 vaccine recipients. However, age and gender were not significantly associated with the severity of KIPI reactions. The severity of KIPI reactions in Covid-19 vaccine recipients has a significant correlation with the characteristics of the respondents, as seen from their allergic history and vaccine stages.

References

Andrzejczak-Grządko, S., Czudy, Z., & Donderska, M. (2021). Side effects after COVID-19 vaccinations among residents of Poland. Eur Rev Med Pharmacol Sci, 25(12), 4418–4421. Retrieved from https://shorturl.asia/0DriT

Astuti, N. P., Nugroho, E. G. Z., Lattu, J. C., Potempu, I. R., & Swandana, D. A. (2021). Persepsi masyarakat terhadap penerimaan vaksinasi COVID-19: Literature review. Jurnal Keperawatan, 13(3), 569–580. https://doi.org/10.32583/keperawatan.v13i3.1363

Daulay, N. A. N. (2021). Model Regresi Spasial Determinan Sosial Kesehatan terhadap Cakupan Vaksinasi COVID-19 di Indonesia Tahun 2021 [Thesis: UIN Syarif Hidayatullah Jakarta-FIKES]. Retrieved from https://repository.uinjkt.ac.id/dspace/handle/123456789/67244

Elsadibah, S., Apriantini, A., & ENSD, L. C. (2023). Young Consumers Behavior in Consuming Honey During the Covid-19 Pandemi: Case Study in Jakarta. Jurnal Ilmu Produksi Dan Teknologi Hasil Peternakan, 11(2), 101–112. https://doi.org/10.29244/jipthp.11.2.101-112

Ernawati, E., & Nurhayati, I. (2023). Overview of AEFI on Survivors and Non-survivors After the Administration of the Covid-19 Vaccine. KnE Social Sciences, 123–129. https://doi.org/10.18502/kss.v8i14.13825

Fahmi, F., Zamroni, M., & Pramono, B. (2023). Kebijakan hukum pemerintah indonesia dalam pelaksanaan vaksinasi covid-19 ditinjau dari hak asasi manusia atas kesehatan. Jurnal Preferensi Hukum, 4(3), 355–372. Retrieved from https://www.ejournal.warmadewa.ac.id/index.php/juprehum/article/download/8242/4912

Fan, Y.-J., Chan, K.-H., & Hung, I. F.-N. (2021). Safety and efficacy of COVID-19 vaccines: a systematic review and meta-analysis of different vaccines at phase 3. Vaccines, 9(9), 989. https://doi.org/10.3390/vaccines9090989

Fauziah, A. F. (2023). Pengaruh Edukasi Metode Audiovisual Terhadap Pengetahuan Tentang Anemia Pada Ibu Hamil Di Wilayah Kerja Uptd Puskesmas Pengasinan [Skripsi: Sekolah Tinggi Ilmu Kesehatan Mitra Keluarga Bekasi]. Retrieved from https://shorturl.asia/92g7H

Febriyanti, N., Choliq, M. I., & Mukti, A. W. (2021). Hubungan tingkat pengetahuan dan kesediaan vaksinasi covid-19 pada warga kelurahan dukuh menanggal kota surabaya. Seminar Nasional Hasil Riset Dan Pengabdian, 3, 36–42. Retrieved from https://snhrp.unipasby.ac.id/prosiding/index.php/snhrp/article/view/168/

Hanung, A., Mahmudah, A., Munawarah, R., & Suharani, D. (2022). Mother’s Satisfaction With Basic Immunization Services During The Covid 19 Pandemic: Mixed Method. Proceeding of International Conference on Science, Health, And Technology, 422–434. https://doi.org/10.47701/icohetech.v3i1.2238

Harismayanti, H., Febriyona, R., Rahim, M. W., Mahmud, D., Hasanah, N., & others. (2021). Covid-19 Vaccination Maternal Services for Pregnant Women in the Work Area of Telaga Community Health Centers. Journal of Asian Multicultural Research for Medical and Health Science Study, 2(4), 56–69. https://doi.org/10.47616/jamrmhss.v2i4.209

Harryandi, A., Bratadana, I. M. D., & Sandyawan, S. D. (2021). Government Liability to Adverse Event Following COVID-19 Vaccine Immunization in Indonesia. 2nd International Conference on Law and Human Rights 2021 (ICLHR 2021), 240–252. https://doi.org/10.2991/assehr.k.211112.031

Hidayat, R., Aini, M. H., Djuliannisaa, Z., Mustika, A. P., Kurniawan, M., Mesiano, T., Harris, S., & others. (2021). Kejadian Ikutan Neurologis Pada Tenaga Kesehatan Rumah Sakit Rujukan Covid-19 Pasca Vaksinasi Mrna-1273 Booster. Neurona, 38(4). Retrieved from https://ejournal.neurona.web.id/index.php/neurona/article/view/273

Hotez, P. J. (2021). Preventing the next pandemic: vaccine diplomacy in a time of anti-science. Johns Hopkins University Press.

Hulu, V. T., Lubis, S. A., & Mahyuni, S. (2022). Gambaran Karakteristik Kejadian Ikutan Pasca Imunisasi Vaksin Covid-19 Di Puskesmas Namorambe Tahun 2021. Jurnal Kedokteran Ibnu Nafis, 11(1), 37–48. https://doi.org/10.30743/jkin.v11i1.353

Kurniawati, D., Yuwindry, I., & Sariyasih, S. (2022). Gambaran Kejadian Ikutan Pasca Imunisasi (KIPI) Setelah Melakukan Vaksinasi Covid-19 Pada Masyarakat Banjarmasin Selatan. Journal Pharmaceutical Care and Sciences, 2(2), 77–84. https://doi.org/10.33859/jpcs.v2i2.187

Lestari, A. F., Sitaresmi, M. N., Haspitaningrum, A., Rachmasari, K. A., Wulandari, R., Sari, S. K., & Ridhayani, F. (2023). Adverse events following immunization (AEFIs) in health workers who receive COVID-19 vaccination at Academic Hospital Universitas Gadjah Mada, Yogyakarta. Indonesian Journal of Pharmacology and Therapy, 4(1). https://doi.org/10.22146/ijpther.6860

Lukas, S., Ramatillah, D. L., Aldi, Y., & Wahyuni, F. S. (2024). Perbandingan Gejala Kejadian Ikutan Pasca Imunisasi Setelah Vaksin Covid-19 Astrazeneca Pertama Dan Kedua Di Central Vaksinasi Uta 45 Jakarta. JIIS (Jurnal Ilmiah Ibnu Sina): Ilmu Farmasi Dan Kesehatan, 9(1), 228–236. https://doi.org/10.36387/jiis.v9i1.1879

Mohammed, I., Nauman, A., Paul, P., Ganesan, S., Chen, K.-H., Jalil, S. M. S., Jaouni, S. H., Kawas, H., Khan, W. A., Vattoth, A. L., & others. (2022). The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review. Human Vaccines & Immunotherapeutics, 18(1), 2027160. https://doi.org/10.1080/21645515.2022.2027160

Nisa, H., Kurniawati, P., Qatrunnida, R., & Mulyono, D. (2023). Factors associated with adverse events following immunization of COVID-19 vaccination. JKKI: Jurnal Kedokteran Dan Kesehatan Indonesia, 144–152. https://doi.org/10.20885/JKKI.Vol14.Iss2.art5

Nurfaizi, A., Afgriyuspita, L. S., Suasti, N. M. A., Muttaqin, U. I., Azizah, B. N., Syahraya, I., Azni, B. D. H., Ramadhani, A. T., Putra, C. J., & Purnami, N. (2023). Knowledge, Attitude, and Perception of Youth Population in Indonesia toward COVID-19 Vaccination. Asian Journal of Health Research, 2(1), 13–21. Retrieved from https://repository.unair.ac.id/126585/

Nursalam, N. (2019). Konsep dan Penerapan Metodologi Penelitian Ilmu Keperawatan. Stikes Perintis Padang.

Plichta, J., Kuna, P., & Panek, M. (2022). Monoclonal antibodies as potential COVID-19 therapeutic agents. Covid, 2(5), 599–620. https://doi.org/10.3390/covid2050045

Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., & others. (2020). Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England Journal of Medicine, 383(27), 2603–2615. https://doi.org/10.1056/NEJMoa2034577

Santoso, A., Sulistyaningrum, I. H., Fathnin, F. H., Nugrahaeni, A. R. D., Rosyid, A., & Banin, S. A. (2022). Analisis Perbedaan Kejadian Ikutan Pasca Imunisasi (KIPI) Vaksin Coronavac Dosis Pertama dan Kedua pada Masyarakat Provinsi Jawa Tengah. Pharmacon: Jurnal Farmasi Indonesia, 19(2), 160–166. https://doi.org/10.23917/pharmacon.v19i2.19746

Simanjorang, C., Surudani, C. J., & Makahaghi, Y. B. (2021). Gambaran awal efek samping vaksin sinovac-coronavac pada petugas kesehatan di kabupaten kepulauan sangihe. Jurnal Ilmiah Sesebanua, 5(2), 43–47. https://doi.org/10.54484/jis.v5i2.465

Tanjaya, W., Leonard, T., & Gaol, L. M. L. (2022). Legal responsibility of vaccine provider on the impact of post immunization following event (AEFI) after vaccination. International Journal of Latin Notary, 2(02), 133–142. https://doi.org/10.61968/journal.v2i02.41

Wu, N., Joyal-Desmarais, K., Ribeiro, P. A. B., Vieira, A. M., Stojanovic, J., Sanuade, C., Yip, D., & Bacon, S. L. (2023). Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. The Lancet Respiratory Medicine, 11(5), 439–452. Retrieved from https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00015-2/fulltext

Author Biographies

Taufiqur Rahman, Politeknik Negeri Madura

Abdan Syakura, Politeknik Negeri Madura

Nur Rahma, Dinas Kesehatan Kabupaten Pamekasan

Cantika Iva Nugrahani, Politeknik Negeri Madura

License

Copyright (c) 2025 Taufiqur Rahman, Abdan Syakura, Nur Rahma, Cantika Iva Nugrahani

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with Jurnal Penelitian Pendidikan IPA, agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, web sites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Jurnal Penelitian Pendidikan IPA.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).